Why the study?
AF is a common arrhythmia in HCM patients indicating poor prognosis, and the value of testing microalbuminuria to improve detection of AF was unknown.
Does testing for microalbuminuria improve the detection of atrial fibrillation in patients with hypertrophic cardiomyopathy?
Does testing for microalbuminuria improve the detection of atrial fibrillation in patients with hypertrophic cardiomyopathy?
Microalbuminuria is independently associated with the presence of atrial fibrillation in patients with hypertrophic cardiomyopathy and may serve as a useful screening marker.
Answers are grounded in this paper and cite their sources.
May support microalbuminuria as a risk marker in hypertrophic cardiomyopathy; leaves open whether testing improves atrial fibrillation detection.
Atrial fibrillation (AF) is common arrhythmia in hypertrophic cardiomyopathy (HCM) patients, and indicate badly prognosis. The aim of this study was to determine the value of testing microalbuminuria (MAU) to improve the detective ability of atrial fibrillation in hypertrophic cardiomyopathy patients. The study was retrospective study. 267 patients with HCM were included from June 2013 to June 2016. Urinary albumin excretion (UAE) was detected by immunoturbidimetry method. AF was defined according to Minnesota codes.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: